# Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica

> **NCT02888496** · — · COMPLETED · sponsor: **University Hospital, Brest** · enrollment: 40 (actual)

## Conditions studied

- Polymyalgia Rheumatica

## Interventions

- **DRUG:** tocilizumab

## Key facts

- **NCT ID:** NCT02888496
- **Lead sponsor:** University Hospital, Brest
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02888496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02888496, "Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02888496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*